hydroxyurea
C2 (Specialized/Technical)Technical/Medical
Definition
Meaning
A chemotherapeutic agent used to treat certain cancers and sickle cell disease, functioning as an antimetabolite that inhibits DNA synthesis.
In broader medical contexts, refers to a specific oral medication with myelosuppressive properties, also used in the management of myeloproliferative neoplasms and as a cytoreductive therapy.
Linguistics
Semantic Notes
The term is almost exclusively used in medical, pharmacological, and oncology contexts. It is a compound noun where 'hydroxy-' refers to the presence of a hydroxyl group and '-urea' indicates its relation to the urea chemical structure, though it is not urea itself.
Dialectal Variation
British vs American Usage
Differences
No significant lexical differences. Spelling and terminology are identical. Dosage regimens and specific approved indications may vary slightly per national health authority guidelines (e.g., NICE in UK vs. FDA in US).
Connotations
Neutral and purely clinical in both regions.
Frequency
Equally low-frequency outside specialized medical fields. Slightly higher frequency in US discourse due to its prominent role in sickle cell disease management protocols.
Vocabulary
Collocations
Grammar
Valency Patterns
[Patient] is on hydroxyurea for [condition].[Doctor] initiated hydroxyurea.[Treatment] involves hydroxyurea.Vocabulary
Synonyms
Neutral
Weak
Usage
Context Usage
Business
Extremely rare; might appear in pharmaceutical company reports or patent discussions.
Academic
Common in medical, pharmacology, and oncology literature, clinical trial reports, and textbook chapters.
Everyday
Virtually never used in everyday conversation unless discussing a personal or family medical condition.
Technical
The primary context of use. Appears in treatment protocols, prescription software, clinical notes, and research papers.
Examples
By Part of Speech
adjective
British English
- The hydroxyurea regimen was adjusted.
- Hydroxyurea-related myelosuppression was observed.
American English
- The hydroxyurea dose was increased.
- Hydroxyurea-induced mucositis is a known side effect.
Examples
By CEFR Level
- The doctor gave her medicine called hydroxyurea.
- Hydroxyurea is a medication that can help patients with sickle cell disease by reducing the frequency of painful crises.
- Despite its myelosuppressive risks, hydroxyurea remains a cornerstone of cytoreductive therapy for polycythaemia vera, necessitating careful haematological monitoring.
Learning
Memory Aids
Mnemonic
HYDROXY-UREA: Remember it's a chemical (HYDROXY group) related to UREA, used to 'smooth' sickle cells and 'slow' cancer cell growth.
Conceptual Metaphor
A KEY that inhibits the LOCK of DNA synthesis; a DAMPENER on rapid cell production.
Watch out
Common Pitfalls
Translation Traps (for Russian speakers)
- Do not translate as 'гидроксимочевина' literally; the standard accepted Russian pharmaceutical term is 'гидроксикарбамид' (hydroxycarbamide).
- Avoid confusion with general 'мочевина' (urea), which is a different compound.
Common Mistakes
- Misspelling as 'hydroxiurea', 'hydroxurea', or 'hydroxylurea'.
- Mispronouncing the 'xyu' cluster as /zaɪu/ instead of /ksi.jʊ/.
- Using it as a countable noun (e.g., 'a hydroxyurea') instead of an uncountable/mass noun (e.g., 'a dose of hydroxyurea').
Practice
Quiz
What is the primary mechanism of action of hydroxyurea?
FAQ
Frequently Asked Questions
Yes, hydroxyurea is classified as an antineoplastic (chemotherapeutic) agent. It is an antimetabolite that interferes with DNA replication.
Its two most prominent uses are: 1) reducing the frequency of painful crises and need for blood transfusions in sickle cell disease, and 2) controlling high blood cell counts in conditions like polycythaemia vera and essential thrombocythaemia.
It is taken orally, usually in capsule form, once daily. The dose is carefully calibrated based on the patient's condition, body size, and blood count response.
The most serious side effects are bone marrow suppression (leading to low blood counts, increasing infection risk), potential for secondary malignancies with long-term use, and severe skin ulcers in some patients. Regular blood tests are mandatory.